Related Experiment Videos
Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression
O S Bang1, F W Ruscetti, M H Lee
1Biological Carcinogenesis and Development Program, SAIC Frederick, Maryland, 21702, USA.
The Journal of Biological Chemistry
|March 29, 1996
Summary
Transforming growth factor-beta1 (TGF-beta1) inhibits myeloid cell growth by altering cell cycle proteins. This study reveals TGF-beta1
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor-beta1 (TGF-beta1) is a known inhibitor of hematopoietic cell proliferation.
- Understanding the precise molecular mechanisms of TGF-beta1-induced growth inhibition is crucial for developing targeted therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms by which TGF-beta1 inhibits IL-3-dependent 32D-123 murine myeloid cell growth.
- To investigate the role of cell cycle regulatory proteins, specifically cyclin E, cyclin-dependent kinase 2 (cdk2), and p107, in TGF-beta1-mediated growth arrest.
Main Methods:
- Cell cycle analysis of 32D-123 murine myeloid cells treated with TGF-beta1.
- Western blot analysis to assess protein phosphorylation and expression levels (cyclin E, cdk2, p107, c-Myc).
- Kinase activity assays for the cyclin E-cdk2 complex.
- Co-immunoprecipitation to study protein-protein interactions (p107-E2F, p107-c-Myc).
- Overexpression and antisense oligodeoxynucleotide studies to validate protein function.
Main Results:
- TGF-beta1 treatment led to hyperphosphorylation of cyclin E and decreased phosphorylation and kinase activity of the cyclin E-cdk2 complex in G1 phase.
- Reduced cyclin E-cdk2 activity correlated with decreased phosphorylation of p107.
- Overexpression of p107 inhibited myeloid cell proliferation, while p107 antisense oligodeoxynucleotides blocked TGF-beta1's inhibitory effect.
- TGF-beta1 increased p107 binding to E2F, decreasing c-Myc protein levels, and p107 directly inhibited E2F transactivation and bound c-Myc.
Conclusions:
- TGF-beta1 inhibits myeloid cell cycle progression by modulating cyclin E and cdk2 activities and their complex formation.
- TGF-beta1 exerts its inhibitory effect through the retinoblastoma-related protein p107, which interacts with E2F and c-Myc.
- These findings reveal a novel mechanism of TGF-beta1-induced cell cycle arrest in myeloid cells involving p107-mediated regulation of E2F and c-Myc.